[Featured Stock] SK Biopharm Gains Early Strength Following KOSPI 200 Inclusion
[Asia Economy Reporter Kum Boryeong] SK Biopharm is showing strong performance from the early trading session on the 10th following the news of its inclusion in the KOSPI 200 index.
At 9:12 AM that day, SK Biopharm's stock price rose 5.03% (9,000 KRW) compared to the previous session, reaching 188,000 KRW.
Hot Picks Today
"Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- Man in His 50s Arrested for Confining Girlfriend in Car After She Announced Breakup
- Assaulted by Elementary Student During Class... No Protection Due to 'Instructor' Status
- "If You Booked This Month, You Almost Lost Out... Why You Should Wait Until 'This Day' Before Paying for Flight Tickets"
SK Biopharm's early inclusion in the KOSPI 200 index has been confirmed for next month. For newly listed stocks on the KOSPI market, if the average daily market capitalization over 15 trading days from the listing date ranks within the top 50 among all common stocks, the stock can be considered for early inclusion in the KOSPI 200 index.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
